Regeneron Pharmaceuticals
REGN
$978.21
Share price
-0.65%
Change (1 day)
30.26%
Change (1 year)
Categories
Regeneron Pharmaceuticals (REGN) - Cash on Hand
Cash on Hand as of March 2024 : $10.51 B
According to Regeneron Pharmaceuticals's latest financial reports the company has $10.51 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Regeneron Pharmaceuticals - Cash on Hand chart (from 2001 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $10.84 B | 40.07% |
| 2022-12-31 | $7.74 B | 35.96% |
| 2021-12-31 | $5.69 B | 58.76% |
| 2020-12-31 | $3.58 B | 11.6% |
| 2019-12-31 | $3.21 B | 14.39% |
| 2018-12-31 | $2.80 B | 99.35% |
| 2017-12-31 | $1.40 B | 35.7% |
| 2016-12-31 | $1.03 B | -0.63% |
| 2015-12-31 | $1.04 B | 16.07% |
| 2014-12-31 | $0.90 B | 29.76% |
| 2013-12-31 | $0.69 B | 125.25% |
| 2012-12-31 | $0.30 B | -41.53% |
| 2011-12-31 | $0.52 B | 111.31% |
| 2010-12-31 | $0.24 B | -26.94% |
| 2009-12-31 | $0.34 B | -28.1% |
| 2008-12-31 | $0.47 B | -38.06% |
| 2007-12-31 | $0.76 B | 66.88% |
| 2006-12-31 | $0.45 B | 53.84% |
| 2005-12-31 | $0.29 B | 0.87% |
| 2004-12-31 | $0.29 B | 0.75% |
| 2003-12-31 | $0.29 B | 11.16% |
| 2002-12-31 | $0.26 B | -31.37% |
| 2001-12-31 | $0.38 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 149.23% | 🇺🇸 USA |
 Novartis NVS | $9.69 B | -7.85% | 🇨🇭 Switzerland |
 Amgen AMGN | $10.94 B | 4.04% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | -5.62% | 🇫🇷 France |
 Biogen BIIB | $1.07 B | -89.79% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $2.37 B | -77.46% | 🇺🇸 USA |